Boston Scientific Launches Promus PREMIERâ„¢ Everolimus-Eluting Platinum Chromium Coronary Stent System In Japan

[PR Newswire] – NATICK, Mass., May 1, 2014 /PRNewswire/ — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIERâ„¢ Everolimus-Eluting … more

View todays social media effects on BSX

View the latest stocks trending across Twitter. Click to view dashboard

See who Boston is hiring next, click here to view